| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.56 | 0.0005 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.42 | 0.002 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.3 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.22 | 5e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0006 |